Barinthus Biotherapeutics plc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Barinthus Biotherapeutics plc. reported Cash And Cash Equivalents At Carrying Value of $70.46 million for the year ending 2025.

  • Barinthus Biotherapeutics plc. showed a decrease of -36.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Barinthus Biotherapeutics plc.'s annual report (Form 10-K), filed with the SEC on March 13, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2020 to 2025), Barinthus Biotherapeutics plc.'s Cash And Cash Equivalents At Carrying Value has grown by 62.8%.
  • Historical annual values: Fiscal year 2025: $70.46 million | Fiscal year 2024: $110.66 million | Fiscal year 2023: $142.09 million | Fiscal year 2022: $194.39 million | Fiscal year 2021: $214.05 million | Fiscal year 2020: $43.27 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: